Chair of Organic Chemistry II, Technische Universität München, Garching bei München, Germany.
National Reference Centre for Staphylococci and Enterococci, Robert Koch Institute, Wernigerode, Germany.
Appl Environ Microbiol. 2020 Aug 3;86(16). doi: 10.1128/AEM.00933-20.
Triclocarban (TCC), a formerly used disinfectant, kills bacteria via an unknown mechanism of action. A structural hallmark is its ,-diaryl urea motif, which is also present in other antibiotics, including the recently reported small molecule PK150. We show here that, like PK150, TCC exhibits an inhibitory effect on menaquinone metabolism via inhibition of the biosynthesis protein demethylmenaquinone methyltransferase (MenG). However, the activity spectrum (MIC) of TCC across a broad range of multidrug-resistant staphylococcus and enterococcus strains was much narrower than that of PK150. Accordingly, TCC did not cause an overactivation of signal peptidase SpsB, a hallmark of the PK150 mode of action. Furthermore, we were able to rule out inhibition of FabI, a confirmed target of the diaryl ether antibiotic triclosan (TCS). Differences in the target profiles of TCC and TCS were further investigated by proteomic analysis, showing complex but rather distinct changes in the protein expression profile of Downregulation of the arginine deiminase pathway provided additional evidence for an effect on bacterial energy metabolism by TCC. TCC's widespread use as an antimicrobial agent has made it a ubiquitous environmental pollutant despite its withdrawal due to ecological and toxicological concerns. With its antibacterial mechanism of action still being unknown, we undertook a comparative target analysis between TCC, PK150 (a recently discovered antibacterial compound with structural resemblance to TCC), and TCS (another widely employed chlorinated biphenyl antimicrobial) in the bacterium We show that there are distinct differences in each compound's mode of action, but also identify a shared target between TCC and PK150, the interference with menaquinone metabolism by inhibition of MenG. The prevailing differences, however, which also manifest in a remarkably better broad-spectrum activity of PK150, suggest that even high levels of TCC or TCS resistance observed by continuous environmental exposure may not affect the potential of PK150 or related ,-diaryl urea compounds as new antibiotic drug candidates against multidrug-resistant infections.
三氯生(TCC)曾作为一种消毒剂,其作用机制未知。它的一个结构特征是含有二芳基脲基,这种结构也存在于其他抗生素中,包括最近报道的小分子 PK150。我们在这里表明,与 PK150 类似,TCC 通过抑制生物合成蛋白脱甲基金霉素甲基转移酶(MenG)来抑制类维生素 K 代谢,从而表现出抑制作用。然而,TCC 对广泛的多药耐药葡萄球菌和肠球菌菌株的活性谱(MIC)要窄得多,远远小于 PK150。因此,TCC 不会像 PK150 的作用模式那样引起信号肽酶 SpsB 的过度激活,SpsB 的过度激活是 PK150 作用模式的一个标志。此外,我们能够排除 FabI 的抑制作用,FabI 是二苯醚抗生素三氯生(TCS)的一个已确认靶点。通过蛋白质组学分析进一步研究了 TCC 和 TCS 的靶标谱差异,结果表明 TCC 对蛋白质表达谱的影响较为复杂,但也相当独特。下调精氨酸脱亚氨酶途径提供了 TCC 对细菌能量代谢产生影响的进一步证据。尽管由于生态和毒理学方面的担忧而被撤出使用,但 TCC 作为一种抗菌剂的广泛使用使其成为一种无处不在的环境污染物。由于其抗菌作用机制仍不清楚,我们在细菌中对 TCC、PK150(一种结构上与 TCC 相似的最近发现的具有抗菌作用的化合物)和 TCS(另一种广泛使用的含氯联苯抗菌剂)进行了比较靶标分析。我们表明,每种化合物的作用模式都有明显的差异,但也确定了 TCC 和 PK150 之间的共同靶标,即通过抑制 MenG 来干扰类维生素 K 代谢。然而,主要的差异,甚至是 PK150 表现出的明显更广泛的广谱活性,表明即使连续的环境暴露导致高水平的 TCC 或 TCS 耐药,也不会影响 PK150 或相关的二芳基脲化合物作为针对多药耐药感染的新型抗生素候选药物的潜力。